NCT06876532 2025-11-18
LUTIBI
Institut Claudius Regaud
Phase NA Recruiting
Clinical Trials
5 trialsNCT05017662 2025-09-04
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
Phase NA Completed
NCT03562091 2020-08-28
OPERA
Ipsen
Completed
NCT03112694 2020-06-02
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Ipsen
Completed
NCT03220087 2018-12-21
RECOSY
Ipsen
Completed